Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1988 Jan;57(1):32–35. doi: 10.1038/bjc.1988.4

Haematogenous dissemination of cells from human renal adenocarcinomas.

D Glaves 1, R P Huben 1, L Weiss 1
PMCID: PMC2246676  PMID: 3279993

Abstract

Estimates were made of the rates at which cancer cells were released directly into the renal vein in patients undergoing radical nephrectomy for primary renal cancer. Cancer cells were counted in blood samples taken from the renal vein using a density gradient centrifugation procedure, and identified using immunocytochemical techniques, on the basis of their cytoskeletal intermediate filament proteins. Cancer cells were released as single cells and multicell emboli in 8/10 patients, in numbers varying widely between 14-7509 emboli ml-1 of blood. Despite a calculated median input into the metastatic process of 3.7 x 10(7) cancer cells per day for at least 180 days, only 3/10 patients had extraperitoneal metastases prior to surgery and only 1 of the remaining disease-free patients subsequently developed distant metastases over a maximum 35 month period. These results are discussed in terms of primary tumour kinetics and metastatic inefficiency.

Full text

PDF
32

Images in this article

33Figure 1
on p.33

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Butler T. P., Gullino P. M. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res. 1975 Mar;35(3):512–516. [PubMed] [Google Scholar]
  2. Cooper D., Schermer A., Sun T. T. Classification of human epithelia and their neoplasms using monoclonal antibodies to keratins: strategies, applications, and limitations. Lab Invest. 1985 Mar;52(3):243–256. [PubMed] [Google Scholar]
  3. Fidler I. J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labeled with 125 I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst. 1970 Oct;45(4):773–782. [PubMed] [Google Scholar]
  4. Fidler I. J. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer. 1973 Mar;9(3):223–227. doi: 10.1016/s0014-2964(73)80022-2. [DOI] [PubMed] [Google Scholar]
  5. Glaves D. Correlation between circulating cancer cells and incidence of metastases. Br J Cancer. 1983 Nov;48(5):665–673. doi: 10.1038/bjc.1983.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Glaves D., Ketch D. A., Asch B. B. Conservation of epithelial cell phenotypes during hematogenous metastasis from mammary carcinomas. J Natl Cancer Inst. 1986 May;76(5):933–938. [PubMed] [Google Scholar]
  7. Glaves D., Mayhew E. Selective therapy of metastasis. I. Quantitation of tumorigenic circulating and covert cancer cells disseminated from metastatic and nonmetastatic tumors. Cancer Drug Deliv. 1984 Fall;1(4):293–302. doi: 10.1089/cdd.1984.1.293. [DOI] [PubMed] [Google Scholar]
  8. Glaves D. Metastasis: reticuloendothelial system and organ retention of disseminated malignant cells. Int J Cancer. 1980 Jul 15;26(1):115–122. doi: 10.1002/ijc.2910260118. [DOI] [PubMed] [Google Scholar]
  9. Lazarides E. Intermediate filaments as mechanical integrators of cellular space. Nature. 1980 Jan 17;283(5744):249–256. doi: 10.1038/283249a0. [DOI] [PubMed] [Google Scholar]
  10. Liotta L. A., Kleinerman J., Saidel G. M. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res. 1974 May;34(5):997–1004. [PubMed] [Google Scholar]
  11. Liotta L. A., Saidel M. G., Kleinerman J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res. 1976 Mar;36(3):889–894. [PubMed] [Google Scholar]
  12. Mayhew E., Glaves D. Quantitation of tumorigenic disseminating and arrested cancer cells. Br J Cancer. 1984 Aug;50(2):159–166. doi: 10.1038/bjc.1984.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. NADEL E. M. PROSPICE--TUMOR CELLS IN CIRCULATING BLOOD. Acta Cytol. 1965 Mar-Apr;9:185–188. [PubMed] [Google Scholar]
  14. Riccardi C., Puccetti P., Santoni A., Herberman R. B. Rapid in vivo assay of mouse natural killer cell activity. J Natl Cancer Inst. 1979 Oct;63(4):1041–1045. [PubMed] [Google Scholar]
  15. Salsbury A. J. The significance of the circulating cancer cell. Cancer Treat Rev. 1975 Mar;2(1):55–72. doi: 10.1016/s0305-7372(75)80015-6. [DOI] [PubMed] [Google Scholar]
  16. Tarin D., Price J. E., Kettlewell M. G., Souter R. G., Vass A. C., Crossley B. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res. 1984 Aug;44(8):3584–3592. [PubMed] [Google Scholar]
  17. Weiss L. Cancer cell traffic from the lungs to the liver: an example of metastatic inefficiency. Int J Cancer. 1980 Mar 15;25(3):385–392. doi: 10.1002/ijc.2910250313. [DOI] [PubMed] [Google Scholar]
  18. Weiss L., Dimitrov D. S. A fluid mechanical analysis of the velocity, adhesion, and destruction of cancer cells in capillaries during metastasis. Cell Biophys. 1984 Mar;6(1):9–22. doi: 10.1007/BF02788577. [DOI] [PubMed] [Google Scholar]
  19. Weiss L. The hemodynamic destruction of circulating cancer cells. Biorheology. 1987;24(2):105–115. doi: 10.3233/bir-1987-24204. [DOI] [PubMed] [Google Scholar]
  20. ZEIDMAN I., McCUTCHEON M., COMAN D. R. Factors affecting the number of tumor metastases; experiments with a transplantable mouse tumor. Cancer Res. 1950 Jun;10(6):357–359. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES